Weak Affinity Chromatography (WAC) enables high-throughput affinity screening of weak ligand-protein interactions (Kds in the uM - mM range) on HPLC-MS instrumentation which generates instant fragment ranking/affinity data from single concentration screening.
Due to features such as its robustness, simplicity, high-throughput and ability to assess very weak binding interactions (mM Kds) while working at low analyte concentrations (<0.1 mM), this technology has proven as an effective alternative for primary Fragment Screening for Fragment Based Drug Discovery. The technology was developed at Swedish universities by Prof Sten Ohlson and co-workers.
Weak Affinity Chromatography AB is a subsidiary of Transientic Interactions AB that develops innovative products
for Life Science with focus on biochemical weak/transient binding interactions - from which we get our name.
keywords: fragment screening, biophysical screening, hit discovery, fragment finding, protein-ligand interactions, intermolecular interactions
Company Details
- Founded
- 2018
- Address
- Medicon Village, Lund,skåne 22381,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.wac.systems
- Keywords
- fragment screening, fragment based drug discovery, fragment based drug design, affinity screening, protein interaction studies, label-free, biomolecular interactions, protein interactions, biophysical screeening.
- HQ
- Lund, Skåne
- Competitors
- Biotage.
Wac Weak Affinity Chromatography Ab Questions
Wac Weak Affinity Chromatography Ab's website is https://www.wac.systems
Wac Weak Affinity Chromatography Ab's LinkedIn profile is https://se.linkedin.com/company/weakaffinitychromatography
Wac Weak Affinity Chromatography Ab's industry is
Biotechnology Research
Wac Weak Affinity Chromatography Ab's top competitors are
Biotage.
Wac Weak Affinity Chromatography Ab's categories are Biotechnology Research
Wac Weak Affinity Chromatography Ab's founding year is 2018
